Ignite Creation Date:
2024-05-06 @ 1:58 PM
Last Modification Date:
2024-10-26 @ 1:22 PM
Study NCT ID:
NCT04171700
Status:
TERMINATED
Last Update Posted:
2023-10-02
First Post:
2019-11-19
Brief Title:
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
Sponsor:
pharmaand GmbH
Organization:
pharmaand GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
Keywords:
| Name | View |
|---|---|
| cervical cancer | View |
| rucaparib | View |
| PARPi | View |
| rare tumor | View |
| solid tumor | View |
| CO-338 | View |
| ovarian cancer | View |
| prostate cancer | View |
| pancreatic cancer | View |
| breast cancer | View |
| lung cancer | View |
| colon cancer | View |
| gastric cancer | View |
| bladder cancer | View |
| colorectal cancer | View |
| PARP inhibitor | View |
| homologous recombination | View |
| DNA repair | View |
| LODESTAR | View |
| germline | View |
| somatic | View |
| BRCA1 | View |
| BRCA2 | View |
| PALB2 | View |
| RAD51C | View |
| RAD51D | View |
| BARD1 | View |
| BRIP1 | View |
| FANCA | View |
| RAD51 | View |
| RAD51B | View |
| sarcoma | View |
| HRR | View |
| HRD | View |
| platinum sensitive | View |
| platinum resistant | View |
| primary peritoneal cancer | View |
| fallopian tube cancer | View |
| tumor agnostic | View |
| basket study | View |
| basket trial | View |
| metastatic | View |
| locally advanced | View |
| esophageal cancer | View |
| leiomyosarcoma | View |
| ampullary carcinoma | View |
| carcinosarcoma | View |
| endometrial cancer | View |